Services
We aim to be an endless incubator in the healthcare industry through multiple initiatives: our IRO (Innovative CRO) business, a new service model supporting drug discovery for domestic and overseas biotech startups; collaborative drug discovery projects with biotech ventures and academia to research and develop promising seeds and regenerative medicine technologies for practical application; external collaboration with academia, VCs, and CDMOs; and investment and financing for business partners both in Japan and abroad.
Innovative Research Organization Business
EP-Bio Partners, Co., Ltd.
We provide one-stop solutions for pharmaceutical planning, development, and launch strategies to bio-venture companies and academic institutions in Japan as well as Chinese and other Asian companies seeking to enter the Japanese market.
Drug Development Business
In collaboration with bio-ventures and academia, we will research and develop promising drug candidates and regenerative medicine technologies and seek to make them commercially practical.
EPS Innovative Medicine (Hong Kong) Ltd.
EPS Innovative Medicine (Japan) Co., Ltd.
FEF Pharmaceutical Co., Ltd.
EPD Hong Kong Ltd.
EPD Co., Ltd.
Biotube Co., Ltd.
